JAGX - Jaguar Health, Inc.
8.51
-0.185 -2.174%
Share volume: 72,263
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$8.70
-0.19
-0.02%
Summary score
53%
Profitability
50%
Dept financing
50%
Liquidity
21%
Performance
66%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
304.14%
Return on assets
-63.12%
Return on sales
-3751.12%
Return on invested capital
76.7%
Total debt ratio
164.26%
Debt ratio change over timeo
0%
Current Ratio
0.56%
Quick Ratio
0.49%
Cash Position Ratio
0.34%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
67.44%
Return on assets
-63.32%
Return on sales
-3110.76%
Return on invested capital
53.32%
Total debt ratio
178.98%
Debt ratio change over timeo
0%
Current Ratio
0.38%
Quick Ratio
0.31%
Cash Position Ratio
0.2%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
14.96%
Return on assets
-4.28%
Return on sales
-233.21%
Return on invested capital
11.89%
Total debt ratio
46.97%
Debt ratio change over time
0%
Current Ratio
0.25%
Quick Ratio
0.13%
Cash Position Ratio
0.04%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | JAGX | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 304.14% | 4.12% | 5.6% | 21.75% |
| Return on assets | -63.12% | 2.87% | 3.58% | 12.86% |
| Return on sales | -3751.12% | 20.56% | 28.52% | 43.62% |
| Return on invested capital | 76.7% | 4.34% | 6.5% | -154.84% |
| Profitability | 50% | 19% | 26% | 52% |
| Total debt ratio | 164.26% | 63.22% | 51.03% | 53.2% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 10% | 8% | 8% |
| Current Ratio | 0.38% | 1.35% | 1.91% | 1.25% |
| Quick Ratio | 0.31% | 0.99% | 1.59% | 0.93% |
| Cash Position Ratio | 0.2% | 0.31% | 0.62% | 0.41% |
| Liquididy | 27% | 44% | 75% | 44% |
| Short-term ratios | JAGX | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 67.44% | 3.9% | 5.53% | 21.28% |
| Return on assets | -63.32% | 2.93% | 3.51% | 12.59% |
| Return on sales | -3110.76% | 20.94% | 28.11% | 43.44% |
| Return on invested capital | 53.32% | 4.21% | 6.14% | -151.68% |
| Profitability | 50% | 21% | 28% | 58% |
| Total debt ratio | 178.98% | 64.39% | 51.75% | 53.34% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 9% | 7% | 7% |
| Current Ratio | 0.38% | 1.35% | 1.91% | 1.25% |
| Quick Ratio | 0.31% | 0.99% | 1.59% | 0.93% |
| Cash Position Ratio | 0.2% | 0.31% | 0.62% | 0.41% |
| Liquididy | 18% | 46% | 75% | 48% |
